There is nothing to pump and nothing worth dumping at this
There is nothing to pump and nothing worth dumping at this point. Im holding for these major studios to climb aboard...oh wait they already have and it was announced by NTEK publically!
The consequences for NTEK if they are lying are multiple lawsuits by these major companies, class action lawsuits, and prison sentencing for fraud! doesnt seem like a logical risk for Al Stone, Mitch Lowe, Aaron Taylor to take when they already have made $Millions over their career, and received a lot of notariety in the industry. So you really think these well known individuals would come together to ruin their reputation over a few million each scamming pennies??? This would be absolutely ludicrous!
As I will be the first one to admit the frustation and anguish that NTEK has caused my family and I, I think scam is completely out of the question.
Only NTEK can dig us out of this hole they led us into, and I still think Ultraflix has a major shot in doing this even if they only deliver on 2/3rds of what they claimed in the shareholder letter.
Honestly these past few months has made NTEK's management look inept as well as shady. The true longs don't need small doses of pumps with missed dates. We need our investor confidence back and that starts with strong management and audited financials whom under promises and over delivers!
All I have left is my DD, hope, and prayer. I believe Ultraflix turns the PPS around in 2015 for good!
Nanotech Entertainment Inc. (NTEK) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Revolutionizing Wearable Graphics with GLTiny There's a fresh breeze blowing through the world of wearable tech, and VeriSilicon's GLTiny seems to be at the heart of it. When the silicon giant out of Shanghai tossed GLTiny into the mix, it wasn't just throwing another chip on the barbie. Oh no, this is a real pivot towards juicing up those smart gadgets strapped to your...
Continue Reading
Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...
Continue Reading
AI Takes Center Stage at Guidewire's Annual Gala Change is constant, but when it comes with a potent mix of AI and insurance, you know things are about to get interesting. Guidewire Software (NYSE: GWRE) is tipping its hat to Beazley, Definity, and RCIS, the standouts at its annual Innovation Awards. Held during their CONNECTIONS Conference in Las Vegas, this year's...
Continue Reading
UPM's Bold Move on the Chessboard In a market that's no stranger to seismic tremors, UPM's decision to move forward with the partial demerger of its Kymmene Corporation is something that raises a few eyebrows. But hey, isn't shaking things up half the fun in this business? The Finnish Financial Supervisory Authority giving a thumbs-up to the supplement listing for WISA...
Continue Reading
Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...
Continue Reading
United Imaging's Remarkable Revenue Surge Coming out of Shanghai, we've got some major numbers to chew on. United Imaging Healthcare (688271.SH)—this isn't your run-of-the-mill medical tech firm—is bringing some serious heat to the market with a 19.43% bump in revenue. We're talking RMB 10.58 billion raked in over just the first nine months of 2026. Those are hefty...
Continue Reading
A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...
Continue Reading
Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...
Continue Reading
Highs Amid Headwinds: MGM China's Standout Quarter Rolling into one's portfolio, MGM China isn't just coasting along—it's smashing some records, despite fierce headwinds. It's not all smooth sailing in Macau's gaming scene, but MGM China has hammered out its third-quarter results with gusto, setting new records for revenue and adjusted EBITDA. These folks aren't just...
Continue Reading
Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....
Continue Reading
=2">More News Articles